Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, MiRNA-based therapy for Alzheimer’s disease: MiRNA-10a ameliorates hippocampal synaptic dysfunctions via down regulation of its target gene, 18/September/2014, 10.44 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Significance: This study suggests that MiRNA-10a, by down regulating its target gene, it may improve hippocampal synaptic dysfunctions. Thereby, it may alleviate pathological symptoms associated with Alzhemer’s disease. Together, this study suggests that pharmacological formulations encompassing “MiRNA-10a or its activators“ may be used to treat Alzhemer’s disease.